- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06572865
Identifying Parents in Child Welfare Services Who Need Mental Health Support: Depression and Anxiety Symptoms
Identifying Parents in Child Welfare Services Who Need Mental Health Support: Depression and Anxiety Symptoms and Associated Factors
The main aim of this study is to examine the occurrence of mental health symptoms among parents referred to the Swedish child welfare services for child maltreatment and other family related risks. Additionally, to examine any variables associated with parents' levels of depression and anxiety.
Parents will respond to questionnaires administered by social workers. The level of depression and anxiety will be descriptively and statistically compared to clinical and normative samples. Additionally, statistical analyses will examine variables associated with parents' mental health symptoms.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
BACKGROUND:
Parental mental illness is associated with various family-related risks, including child maltreatment and children developing own psychiatric conditions. Studies indicate that parental mental illness is more prevalent in families into contact with the child welfare system due to child maltreatment or other risk conditions. However, there is a lack of studies that routinely examine the well-being of parents reported for child maltreatment. Furthermore, there is limited knowledge of whether the severity of parental symptoms varies based on the reasons for the child welfare report.
PURPOSE AND RESEARCH QUESTIONS:
The main aim of this study is to assess the occurrence of mental health symptoms among parents referred to the child welfare services (CWS) and whether any factors are associated with the level of symptoms. The research questions are:
- Is the average level of depression and anxiety among parents reported to CWS different from that in normative and clinical populations?
- Are parent and family characteristics, the reason for the child welfare involvement, or previous involvement with CWS associated with parents' levels of depression and anxiety?
METHODS:
This is a cross-sectional study using data collected within a feasibility study of the Collaboration-Screening-Referral model (in Swedish: Samverkan-Screening-Hänvisning - SSH) - an approach to screen parents for symptoms of mental illness using structured questionnaires, establish intra-agency collaboration, and refer to mental health services. An evaluation of the effects, feasibility and experiences of the SSH-model is presented in a separate study: "Screening to Identify Parents in Need of Mental Health Support: A Feasibility Study in Child Welfare Services". The present study presents data from the questionnaire administered to parents.
CWS agencies in Swedish municipalities will be recruited to take part in the research project. Social workers will receive training in employing screening for depression and anxiety. Then, they will administer a questionnaire measuring symptoms of depression and anxiety to parents they meet as a part of routine work. They will be encouraged to present the screening to every eligible parent they meet. When parents have responded to questionnaires, it is followed by a discussion about well-being and support needs. When relevant, the social worker provides information about what mental health support is available.
Parents' data will be anonymous. The multiple-choice questions will be restricted and phrased in a way that prevents identification. The survey will be made available in several languages.
SAMPLE SIZE CALCULATION AND ANALYSES:
Mean values from the instruments will be presented descriptively. Also, compared statistically (using t-test or ANOVA) to established cut-off values/clinical samples as well as data from parents in the general population. To take account of possible nesting effects resulting of parents from the same families responding, the alpha will conservatively be set to 0.025. At least 290 participants are needed for an 80% power (alpha = 0.025) to detect a small mean difference (d = 0.20). Additionally, multiple linear regression analyses will examine variables associated with parents' symptoms.
Study Type
Enrollment (Estimated)
Contacts and Locations
Study Contact
- Name: Martin Forster
- Phone Number: +46709424225
- Email: martin.forster@ki.se
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- A parental role in relation to a child 0-17 years old (the participant does not be a guardian or biological parent, can also be, for example, a partner to a parent).
- A child welfare report has been filed for the child or the parent has reached out to the CWS themselves.
Exclusion Criteria:
- Not able to read questionnaire in any available language and interpreter not available at the social services.
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Parents reported to the child welfare services
Adults who are into contact with the Swedish CWS due to a child welfare report.
The adults have a parental role in relation to a child 0-17 years old (referred to as 'parents').
|
Parents respond to questionnaires assessing depression and anxiety.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
The Patient Health Questionnaire
Time Frame: At inclusion, each participant will be assessed one time only.
|
The Patient Health Questionnaire (PHQ-9) will be used to assess depressive symptoms, including suicidal ideation, over the last two weeks (9 questions).
Items are scored 0-3, resulting in a total score of 0-27.
Higher scores indicate more symptoms of depression.
|
At inclusion, each participant will be assessed one time only.
|
|
The GAD-7
Time Frame: At inclusion, each participant will be assessed one time only.
|
The 7-item GAD-7 will measure symptoms of anxiety.
Items are scored 0-3, resulting in a total score of 0-21.
Higher scores indicate more symptoms of anxiety.
|
At inclusion, each participant will be assessed one time only.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Parents' background
Time Frame: At inclusion, each participant will be assessed one time only.
|
Parent will respond to a few questions about their background when responding to the screening questionnaire.
|
At inclusion, each participant will be assessed one time only.
|
|
Parents' contact with mental health services
Time Frame: At inclusion, each participant will be assessed one time only.
|
In the screening questionnaire, parents will be asked whether they are currently or have previously been in contact with healthcare services for their mental health.
|
At inclusion, each participant will be assessed one time only.
|
|
Characteristics of the contact with child welfare services
Time Frame: At inclusion, each participant will be assessed one time only.
|
In the parents' questionnaires, previous contact with child welfare services will be recorded, along with the reason for the current involvement with child welfare services.
|
At inclusion, each participant will be assessed one time only.
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Martin Forster, Karolinska Institutet
Study record dates
Study Major Dates
Study Start (Estimated)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Estimated)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- Parent symptoms CWS
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Depression
-
Massachusetts General HospitalRecruitingDepression | Depression - Major Depressive Disorder | Depression Chronic | Depression in Adults | Depression Disorders | Depression DisorderUnited States
-
University of California, San FranciscoNational Center for Complementary and Integrative Health (NCCIH)Active, not recruitingDepression Moderate | Depression Mild | Depression, TeenUnited States
-
ProgenaBiomeWithdrawnDepression | Depression, Postpartum | Depression, Anxiety | Depression Moderate | Depression Severe | Clinical Depression | Depression in Remission | Depression, Endogenous | Depression ChronicUnited States
-
Sorlandet Hospital HFUniversity of Oslo; Karolinska Institutet; Australian Catholic University; Helse...RecruitingAnxiety | Anxiety Depression | Depression Anxiety Disorder | Depression - Major Depressive DisorderNorway
-
Lipocine Inc.CompletedDepression, Postpartum | Postnatal Depression | Peripartum Depression | Depression, Post-Partum | Postpartum Depression (PPD) | Post-Natal DepressionUnited States
-
Washington University School of MedicineCompletedTreatment Resistant Depression | Late Life Depression | Geriatric Depression | Refractory Depression | Therapy-Resistant DepressionUnited States, Canada
-
Kintsugi Mindful Wellness, Inc.Sonar Strategies; Vituity PsychiatryActive, not recruitingDepression | Depression Moderate | Depression Severe | Depression MildUnited States
-
Kintsugi Mindful Wellness, Inc.Sonar Strategies; Kolby Walker, DO; Brittany KimbleRecruitingDepression | Depression Moderate | Depression Severe | Depression MildUnited States
-
University of CincinnatiNational Center for Complementary and Integrative Health (NCCIH)RecruitingMild DepressionUnited States
-
University of MinnesotaCompletedDepression SymptomsUnited States
Clinical Trials on Screening for depression and anxiety
-
Vanderbilt University Medical CenterCompleted
-
Centre Hospitalier Universitaire de Saint EtienneRecruitingDepression, Anxiety | Generalized Anxiety | Survivors of Childhood Cancer | Introspective & Anxiety-Prone PatientFrance
-
Linkoeping UniversityCompletedDepression | Anxiety DisordersSweden
-
NYU Langone HealthCompleted
-
Universidad de los Andes, ChileNot yet recruiting
-
San Diego State UniversityNational Institute of Mental Health (NIMH); Kaiser Permanente; OCHIN, Inc.Enrolling by invitationDepression, AnxietyUnited States
-
Rafael NaviaCompletedDepressive and Anxiety DisordersEcuador
-
University of North Carolina, Chapel HillFogarty AIDS international training research programCompleted
-
Clinical Directors NetworkCompletedDepression | Cervical Cancer Screening | Breast Cancer Screening | Colorectal Cancer ScreeningUnited States
-
Universitätsklinikum Hamburg-EppendorfGerman Research FoundationCompletedDepression | Major Depressive DisorderGermany